Essar Oil and Gas Exploration & Production (EOGEPL) is injecting $100 million into its flagship Raniganj East CBM block in West Bengal, aiming to scale up domestic natural gas production and explore shale potential in a bid to reduce India's import reliance.
Chevron's fourth-quarter profit fell 12.5% year-over-year, pressured by lower oil prices, but the energy giant highlighted robust operational cash flow, record production levels following its Hess acquisition, and significant progress in its long-term strategic projects.
A discounted cash flow analysis suggests Australis Oil & Gas (ASX:ATS) shares may be trading close to their intrinsic value. We examine the model's assumptions and the broader context for the energy junior.
In a strategic pivot, Tesla's Q4 earnings call revealed plans to halt Model S and X production at its Fremont plant, repurposing the space for a massive push into humanoid robotics with the Optimus project, as Elon Musk outlines a vision for a million-unit annual output.
Magnolia Oil & Gas Corporation announces a dividend increase to $0.165 per share, as strong earnings growth and a sustainable payout ratio paint an optimistic financial picture for the Houston-based independent producer.
A recent discounted cash flow analysis suggests D&O Green Technologies Berhad's stock may be significantly undervalued, trading around RM0.60 against a calculated fair value of RM0.89. The semiconductor-focused firm's current valuation presents a notable gap for investors to consider.
Campbell Soup Company announces the closure of its Hyannis, Massachusetts snacks facility, consolidating Cape Cod and Kettle Brand production. The move signals a significant supply chain realignment as the CPB stock shows mixed performance, raising questions about long-term value and market positioning.
Chevron capped off a year of strategic execution with record global production and industry-leading free cash flow growth, while outlining ambitious expansion plans from the Caspian to the Caribbean.
Arthur J. Gallagher & Co. reported robust revenue growth exceeding 30% for the fourth quarter of 2025, driven by a healthy mergers and acquisitions pipeline and resilient performance in key sectors. Leadership expressed confidence in navigating a softening property insurance market while maintaining stable casualty pricing and talent retention.
Barclays initiates coverage of 4D Molecular Therapeutics with an Overweight rating and a $33 price target, citing a favorable industry backdrop with potential M&A tailwinds and shifting focus away from drug pricing pressures. The gene therapy developer also outlined key clinical milestones expected through 2026.
New data reveals a two-horse race in mining sector legal advisory, with Webber Wentzel leading by total deal value and Blake Cassels & Graydon topping the charts by number of transactions in a year marked by megadeals.
While Bed Bath & Beyond shares fell 13%, insiders who bought in the last year remain in profit, highlighting a potential disconnect between internal confidence and market sentiment.
Insurance brokerage giant Brown & Brown sees a key price target cut to $81 following its fourth-quarter earnings, which revealed robust fee growth but concerns over slowing organic revenue expansion.
A deep dive into the conflicting signals from Church & Dwight's stock valuation. While a discounted cash flow model suggests a significant discount, its premium P/E ratio tells a different story, leaving investors to weigh pricing power against market expectations.
The S&P 500 is home to market leaders, but not all its constituents are created equal. We examine one company navigating challenges and two others positioned for potential growth, providing context on their valuations and market positions.
Mazda Motor Corporation's global vehicle production saw a significant rebound in December 2025, offering a positive end to a year where overall output and sales declined. The recovery was driven by strong domestic performance and a mixed picture overseas.
Shares of the direct-to-consumer telehealth company Hims & Hers have been halved over the past six months, trading near $27. Investors are now weighing whether the steep sell-off presents a buying opportunity or signals deeper troubles ahead.
Honda Motor posted a 4.3% year-on-year increase in global vehicle production for December 2025, recovering from a steep November slump. However, the automaker's full-year 2025 output fell nearly 9%, highlighting uneven regional performance with North America rebounding sharply while Asia, particularly China, saw significant declines.
Despite posting robust year-over-year growth, Brown & Brown's Q4 revenue miss triggered a sharp sell-off. The earnings call revealed deeper pressures, from integration challenges and talent poaching to market normalization, setting the stage for a pivotal 2024.
The S&P 500's 1.4% rise in January 2026 aligns with a decades-old market indicator, the 'January Barometer,' which historically signals strong full-year performance. Analysis of the past 40 years shows an 80% probability of gains through December following a positive January.
